Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$649M |
| 2 |
Nike
NKE
|
+$453M |
| 3 |
Tesla
TSLA
|
+$431M |
| 4 |
AstraZeneca
AZN
|
+$389M |
| 5 |
Coca-Cola
KO
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$897M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$578M |
| 3 |
Moderna
MRNA
|
+$438M |
| 4 |
Apple
AAPL
|
+$417M |
| 5 |
Aon
AON
|
+$386M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.4% |
| 2 | Healthcare | 20.27% |
| 3 | Consumer Staples | 11.15% |
| 4 | Consumer Discretionary | 9.81% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
HBT Financial
HBT
$1.32B
| $997K | ﹤0.01% |
64,107
-12,793
| -17% | -$207K |
|
|
AGFS
2552
DELISTED
AgroFresh Solutions Inc
AGFS
| $996K | ﹤0.01% |
461,111
-281,713
| -38% | -$569K |
|
|
THR
2553
DELISTED
Thermon Group Holdings
THR
| $993K | ﹤0.01% |
57,388
-19,812
| -26% | -$329K |
|
2554
iShares MSCI USA Min Vol Factor ETF
USMV
$24.1B
| $992K | ﹤0.01% |
+13,500
| New | +$1.03M |
|
|
FRTX
2555
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $992K | ﹤0.01% |
30,618
-3,138
| -9% | -$102K |
|
|
LGO
2556
Largo
LGO
$67.7M
| $990K | ﹤0.01% |
+94,210
| New | +$1.32M |
|
|
VNE
2557
DELISTED
Veoneer, Inc.
VNE
| $990K | ﹤0.01% |
28,875
-25,894
| -47% | -$823K |
|
2558
BCE
BCE
$21.2B
| $986K | ﹤0.01% |
19,698
-36,400
| -65% | -$1.84M |
|
2559
Blue Ridge Bankshares
BRBS
$331M
| $985K | ﹤0.01% |
56,000
+23,300
| +71% | +$407K |
|
2560
Diageo
DEO
$51.6B
| $984K | ﹤0.01% |
+5,100
| New | +$988K |
|
|
DXYN
2561
DELISTED
Dixie Group Inc
DXYN
| $982K | ﹤0.01% |
202,100
-7,300
| -3% | -$28.5K |
|
|
GFED
2562
DELISTED
Guaranty Federal Bancshares In
GFED
| $981K | ﹤0.01% |
40,800
-500
| -1% | -$12.1K |
|
|
PRTK
2563
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $980K | ﹤0.01% |
201,624
-226,800
| -53% | -$1.25M |
|
2564
MGE Energy Inc
MGEE
$3.05B
| $978K | ﹤0.01% |
13,300
-2,200
| -14% | -$172K |
|
2565
Genworth Financial
GNW
$3.72B
| $976K | ﹤0.01% |
260,200
+209,165
| +410% | +$745K |
|
2566
iShares Europe ETF
IEV
$1.69B
| $975K | ﹤0.01% |
18,700
+7,900
| +73% | +$428K |
|
2567
Keros Therapeutics
KROS
$211M
| $972K | ﹤0.01% |
+24,572
| New | +$874K |
|
2568
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.86B
| $971K | ﹤0.01% |
+18,900
| New | +$984K |
|
|
MTCR
2569
DELISTED
Metacrine, Inc. Common Stock
MTCR
| $971K | ﹤0.01% |
283,100
+203,200
| +254% | +$634K |
|
|
HYPD
2570
Hyperion DeFi Inc
HYPD
$40.5M
| $969K | ﹤0.01% |
2,473
+609
| +33% | +$226K |
|
|
ATXS
2571
DELISTED
Astria Therapeutics
ATXS
| $967K | ﹤0.01% |
109,353
+46,443
| +74% | +$445K |
|
2572
Twin Disc
TWIN
$337M
| $967K | ﹤0.01% |
90,693
+7,500
| +9% | +$98K |
|
|
MREO
2573
Mereo BioPharma
MREO
$48.8M
| $965K | ﹤0.01% |
398,900
+113,800
| +40% | +$301K |
|
2574
Solid Biosciences
SLDB
$857M
| $960K | ﹤0.01% |
26,790
+1,138
| +4% | +$48.3K |
|
|
SOGP
2575
Sound Group
SOGP
$53.2M
| $959K | ﹤0.01% |
30,238
-54,080
| -64% | -$2.43M |
|
Similar funds
Renaissance Technologies's Q3 2021 Portfolio in Review
As of Q3 2021, Renaissance Technologies held 4,070 positions worth $77.4B, down 3.3% from $80.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q3 2021 filing shows 663 new, 931 increased, 1,797 reduced and 653 closed positions. Its largest new stake was Adobe: 1,030,433 shares worth $593M. The largest sale was Amazon, an estimated $897M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Staples.
- Renaissance Technologies's largest Q3 2021 buy was Adobe: 1,030,433 shares worth $593M.
- Renaissance Technologies added most to Nike in Q3 2021, an estimated $453M increase.
- Renaissance Technologies's biggest Q3 2021 reduction was Moderna, cutting an estimated $438M.
- Renaissance Technologies fully exited Amazon in Q3 2021, selling an estimated $897M.
- Renaissance Technologies's ten largest holdings make up 12% of its $77.4B portfolio in Q3 2021.
- Renaissance Technologies opened 663 new positions and closed 653 in Q3 2021.
- Renaissance Technologies's portfolio value fell 3.3% quarter-over-quarter to $77.4B.
Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.